IL-33 and ILC2 in pancreatic cancer: good, bad or a bit of both?
Saved in:
| Title: | IL-33 and ILC2 in pancreatic cancer: good, bad or a bit of both? |
|---|---|
| Authors: | Simpson C; University of Cambridge, CRUK Cambridge Institute, Cambridge, CB2 0RE, UK., Yip T; University of Cambridge, CRUK Cambridge Institute, Cambridge, CB2 0RE, UK., Halim TYF; University of Cambridge, CRUK Cambridge Institute, Cambridge, CB2 0RE, UK. Electronic address: Tim.Halim@cruk.cam.ac.uk. |
| Source: | Trends in cancer [Trends Cancer] 2025 Apr; Vol. 11 (4), pp. 274-275. Date of Electronic Publication: 2025 Mar 17. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Cell Press Country of Publication: United States NLM ID: 101665956 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2405-8025 (Electronic) Linking ISSN: 24058025 NLM ISO Abbreviation: Trends Cancer Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
